Recently, pro-gastrin-releasing peptide (pro-GRP) became available as an alternative sensitive, specific and reliable tumor marker for patients with small cell lung cancer (SCLC), both in limited (LD) and diffuse disease (DD)
Here we review the role of tissutal and circulating biomarkers in the management of lung cancer. In ...
We retrospectively studied the single and combined diag-nostic value of carcinoembryonic antigen (CE...
Small cell lung cancer (SCLC) accounts for approximately 25% of all lung cancers. It is distinguishe...
Ewa Wojcik, Jan Kanty Kulpa Department of Clinical Biochemistry, Maria Skłodowska-Curie Memoria...
The standardisation process consisted of determining tumour marker levels in all relevant population...
Context.- Gastrin-releasing peptide receptors (GRPRs) activate mitogen-activated protein kinase sign...
This study aimed to investigate whether changes in progastrin-releasing peptide (ProGRP) levels corr...
Lung cancer is the number one cause of cancer death; however, no specific serum biomarker is availab...
We retrospectively studied the single and combined diagnostic value of carcinoembryonic antigen (CEA...
Background: Pro-gastrin releasing peptide ( ProGRP) concentrations in blood play an important role i...
The effect of the protease inhibitors BBI and aprotinin on the in vitro clonal growth of two human s...
© TÜBİTAK.Background/aim: It is not always easy to diagnose pulmonary neuroendocrine tumors (PNETs)....
Lung cancer is the most common cause of cancer-related death, worldwide. Historically, lung cancer h...
Lung cancer is the most common cause of cancer-related death, worldwide. Historically, lung cancer h...
reduction in Bcl-2 and Bcl-xL transcripts. Furthermore, in both the GR-expressing adenovirus-cted ce...
Here we review the role of tissutal and circulating biomarkers in the management of lung cancer. In ...
We retrospectively studied the single and combined diag-nostic value of carcinoembryonic antigen (CE...
Small cell lung cancer (SCLC) accounts for approximately 25% of all lung cancers. It is distinguishe...
Ewa Wojcik, Jan Kanty Kulpa Department of Clinical Biochemistry, Maria Skłodowska-Curie Memoria...
The standardisation process consisted of determining tumour marker levels in all relevant population...
Context.- Gastrin-releasing peptide receptors (GRPRs) activate mitogen-activated protein kinase sign...
This study aimed to investigate whether changes in progastrin-releasing peptide (ProGRP) levels corr...
Lung cancer is the number one cause of cancer death; however, no specific serum biomarker is availab...
We retrospectively studied the single and combined diagnostic value of carcinoembryonic antigen (CEA...
Background: Pro-gastrin releasing peptide ( ProGRP) concentrations in blood play an important role i...
The effect of the protease inhibitors BBI and aprotinin on the in vitro clonal growth of two human s...
© TÜBİTAK.Background/aim: It is not always easy to diagnose pulmonary neuroendocrine tumors (PNETs)....
Lung cancer is the most common cause of cancer-related death, worldwide. Historically, lung cancer h...
Lung cancer is the most common cause of cancer-related death, worldwide. Historically, lung cancer h...
reduction in Bcl-2 and Bcl-xL transcripts. Furthermore, in both the GR-expressing adenovirus-cted ce...
Here we review the role of tissutal and circulating biomarkers in the management of lung cancer. In ...
We retrospectively studied the single and combined diag-nostic value of carcinoembryonic antigen (CE...
Small cell lung cancer (SCLC) accounts for approximately 25% of all lung cancers. It is distinguishe...
DOI
Add to ORKG